期刊文献+

新疆伊犁州接受抗病毒治疗的艾滋病患者流行病学及临床特征分析 被引量:1

The Epidemiology and Clinical Features Among AIDS Patients Taking Highly Active Antiretroviral in Yili City,Xinjiang Uygur Autonomous Region
在线阅读 下载PDF
导出
摘要 目的了解新疆维吾尔自治区伊犁州接受抗病毒治疗的艾滋病患者的基本状况。方法对符合抗病毒治疗标准的伊利州艾滋病患者进行问卷调查,并采血进行实验室检测。结果伊利州艾滋病抗病毒治疗患者以男性青壮年为主,异性性传播、静脉注射吸毒为主要感染途径,HCV和HIV的共感染率达35.83%,85.32%的抗病毒治疗者处于艾滋病的Ⅰ期或Ⅱ期,13.50%的艾滋病人同时伴有机会性感染,6.84%的艾滋病人患有结核。结论伊犁州大部分接受抗病毒治疗的艾滋病人基本状况良好,但需进一步完善相关信息。 Objective To explore basic information of AIDS patients taking highly active antiretroviral( HAART).Methods All subjects in this study were surveied,and blood sample were collected to test. Results Most of these AIDS patients were young male. The major infectious route was heterosexual transmission,followed by intravenous drug use. The co-infection of HIV and HCV reached to 35. 83%. 85. 32% of AIDS were in Ⅰor Ⅱ phase according to WHO criteria. The functions of liver and kidney were better for most of patients. 13. 50% patients suffered from opportunistic infection and 6. 84% with TB infection. Conclusion Although the effect of HAART on AIDS patients living in Yili City were better,more high quality information were needed.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2016年第3期271-273,320,共4页 The Chinese Journal of Dermatovenereology
关键词 艾滋病 抗病毒治疗 临床特征 艾滋病相关机会致病菌感染 AIDS Antiretroviral treatment Clinical features AIDS related opportunistic infection
  • 相关文献

参考文献15

  • 1Valentin LD, Andrea J, Houda H, et al. Achieving a cure for HIV in- fection: do we have reasons to be optimistic? [ J]. Journal of antimicro- bial Chemotherapy,2012,67 (5) : 1063 - 1074.
  • 2李太生.中国的艾滋病抗病毒治疗要充分考虑国情[J].中华医学杂志,2012,92(17):1153-1154. 被引量:9
  • 3李太生.如何提高我国抗艾滋病病毒治疗成功率[J].中华医学杂志,2011,91(21):1441-1442. 被引量:17
  • 4Zhang F, Dou Z, Yu L, et al. The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China [J]. Clinical infectious Disease, 2008, 47 (6) :825 - 833.
  • 5Zhang FJ, Dou ZH, Ma Y, et al. Five-year outcomes of the China na- tional free antiretroviral treatment program[J]. Annals of Internal Medi- cine, 2009,151 (4) :241 -251.
  • 6Wang N, Wang L, Wu ZY, et al. Estimating the number of people liv- ing with H1V/AIDS in China: 2003-09 [J]. International Journal of Epi- denaiology, 2010,39(Suppl 2) :ii21 - ii28.
  • 7Ma Y, Zhao DC, Yu L, et al. Predictors of virologic failure in HIV-1-in-fected adults on first line antiretroviral therapy in eight provinces in China[J]. Clinical Infectious Disease, 2010, 50(2) : 264 -271.
  • 8肖占沛,郭宏雄,还锡萍,刘晓燕,徐晓琴,胡海洋,杨传坤,羊海涛.江苏省抗病毒治疗者HIV-1基因耐药性及影响因素的分析[J].南京医科大学学报(自然科学版),2012,32(1):16-19. 被引量:9
  • 9Huldrych FG, Judith AA, Joseph JE, et al. Antiretroviral treatment of a- dult HIV infection 2014 recommendations of the international antiviral society-USA Panel[J]. JAMA, 2014, 312(4) :410 -425.
  • 10Intasan J, Bunupuradah T, Vonthanak S, et al. Comparison of adher- ence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial [J]. AIDS Patient Care STDS, 2014, 28 ( 6 ) : 296 - 302.

二级参考文献22

共引文献32

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部